title: Pleiotropic effects of statins on cardiovascular events in the Japanese Coronary Artery Disease study.
abstract: We analyzed 6317 patients with a baseline LDL-cholesterol level of 70 to 130 mg/dL among 13,812 patients of the Japanese Coronary Artery Disease (JCAD) study. We divided the patients into 2 groups according to statin treatment and its lipophilicity. We compared the incidence of all-cause events between 2000 statin-treated patients and 4317 patients without statins during a median follow-up period of 1092 days (range 0 to 1676 days). After propensity score matching (n=1641, for each group), Kaplan-Meier analysis showed 25% reduction in the incidence of all-cause events with statin treatment (p=0.0016). The incidence of all-cause events was also compared between 1139 patients with hydrophilic statin and 861 patients with lipophilic statin. After propensity score matching (n=778, for each group), Kaplan-Meier analysis showed no significant difference in the incidence of all-cause events with respect to lipophilicity. Subgroup analysis of the JCAD study suggested a lipid-independent beneficial treatment effect of statins on all-cause events, and these favorable effects were comparable between the hydrophilic and lipophilic statins.
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Fujita
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Yamazaki
authors.forename: Doubun
authors.initials: D
authors.lastname: Hayashi
authors.forename: Takahide
authors.initials: T
authors.lastname: Kohro
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Okada
authors.forename: Ryozo
authors.initials: R
authors.lastname: Nagai
mesh_terms: D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000187:drug effects*; D003324:Coronary Artery Disease / Q000097:blood* / Q000453:epidemiology* / Q000378:metabolism / Q000517:prevention & control; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors